© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Prevention
How Well Do U=U and PrEP Work? The CDC Updates Its Answers
#PrEP
#Cure
A sample social media post for SHAAD

Southern HIV/AIDS Awareness Day 2019 [VIDEO]

#SHAAD debuts Tuesday, August 20. Here’s how you can be part of the Southern Solution.

Concerns: Women’s Disparities

Black women have a HIV rate 15 times higher than white women.

Prevention: Zero Transmissions

Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.

The International AIDS Conference’s Most Vital Findings

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

CDC Director Visits Ohio to Share Ideas for Ending the HIV Epidemic

Three counties in the state are among 48 nationwide eligible for federal HIV resources. Here’s what’s fueling new cases in these regions.

Under New Family Planning Restrictions, the Gag Rule Comes to America

Changes to the Title X program concern abortion and target Planned Parenthood. But they should alarm the HIV community.

MUST read

Safer Sex
drug users passing a syringe
Safer Injecting
Treatment-as-Prevention (TasP)

What’s Behind the Recent Media Ads Looking for PLWH and People Taking PrEP with Side Effects From Truvada?

The chairs of the HIV Medicine Association and the American Academy of HIV Medicine urge health care advice from clinicians, not lawyers.

HIV Test-and-Treat Program Would Greatly Lower HIV in Africa

The PopART study is one of three that have recently reported findings of such programs in sub-Saharan Africa.
Trump at a Cincinnati rally on August 1, 2019.

Trump Says We’re Ending AIDS and Curing Childhood Cancer Very Shortly [VIDEO]

How true is his statement? These facts add context.

WHO Endorses On-Demand PrEP for Gay and Bi Men

On-demand, or 2-1-1, PrEP requires taking only four doses of Truvada during the days surrounding sex.

Providing Same-Day PrEP Is Feasible in Latin America

Researchers provided an initial Truvada prescription to eligible gay and bi men and trans women at their first appointment.

In San Francisco, Stopping PrEP Is Linked to 8-Fold Increase in HIV Rate

Nationwide, significant proportions of PrEP-using populations do not stay on Truvada for long.

Upping Ongoing PrEP Use May Be as Vital as Getting Men to Start

A modeling study projected the impact of various strategies for improving PrEP use among young Black gay and bi men in Illinois.

Descovy PrEP Produces Higher Drug Levels—But Does it Matter?

Descovy may offer protection against HIV faster and for longer than Truvada, but its higher cost may outweigh the apparent benefits.

New HIV Vaccine Trial in Americas and Europe Backed by Promising Earlier Study

The ASCENT trial found that the vaccine regimen that was advanced to the forthcoming Mosaico trial prompted a strong immune response.

What a U=U Leader Thinks About the CDC’s Updated Data on HIV Risk

“We’re very happy,” says PAC’s Murray Penner. But he’d like the federal agency to take these additional steps.
Advertisement
Features
Opinions